The Pharmacokinetics, Tolerability and Safety of Brexpiprazole in Healthy Chinese Subjects
Status:
Completed
Trial end date:
2020-05-18
Target enrollment:
Participant gender:
Summary
This study is a single-center, open-label study evaluating the pharmacokinetics, tolerability
and safety of single dose oral brexpiprazole tablets in healthy Chinese subjects. A total of
30 healthy adult subjects are to be enrolled into the study. Three dose groups will be set
up, with about 10 subjects in each dose group. Subjects will enter 1 mg, 2 mg and 4 mg dose
groups in sequence.